Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare ...

Nelson Peltz’s Trian Fund Management plans to push Solventum (SOLV) to separate more of its businesses after the company sold its filtration ...

Unilever shocked the market when it announced its chief exec Hein Schumacher would be replaced by finance chief Fernando ...

In today’s CEO Daily: Peter Vanham on activist investor Nelson Peltz and ... to CEO Daily on Wednesday, Peltz made a clear endorsement of the new CEO: “Trian believes continued operational ...

Nelson Peltz’s Trian Fund Management disclosed in an SEC filing its holdings as of December 31, 2024. Trian increased its stake in a number of holdings, including by size of previous position ...

Unilever's board, which includes billionaire activist investor Nelson Peltz, was unified in its decision to oust CEO Hein ...

The most notable increase was Solventum Corp (NYSE:SOLV), with an additional 1,336,564 shares, bringing the total to 8,462,819 shares. This adjustment represents a significant 18.76% increase in ...

Sales in the segment were $1.17 billion during the quarter. The company's performance has come under scrutiny from activist investor Nelson Peltz. Peltz's Trian Fund Management said in a letter to ...

Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in April 2024.

Feb 26 (Reuters) - Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum (SOLV.N), opens new tab for further business separations following the company's $4.1 billion ...